Personalized biomedical solutions, built around each patient.
Hong Kong Relife Biological Technology Ltd. develops customized biomedical solutions based on cancer vaccine and NK cell science, designed around each patient’s own cells and provided only through registered doctors, in line with Hong Kong regulations.
Precision cellsAI-drivenA healthier future
精準細胞 × AI驅動 × 更健康的未來
We imagine a future where medicine is designed from each person’s own cells, and where AI turns those signals into insight in days, not years.
Three ideas shape the future we are building.
Every patient is unique
No two tumors share the same mutations, so no two solutions should be the same. Each plan starts from the patient’s own cells.
AI as a partner in care
AI helps analyze genomes, images and laboratory results. With consent, de-identified data helps our models improve over time.
Information, not promises
Organoid and genomic results give patients and doctors more information from the patient’s own cells. We never promise outcomes.
Our mission
To develop personalized cancer vaccine and NK cell solutions responsibly, combining living human models, AI and clinical expertise, and to make them available to patients only through registered doctors and approved pathways.
How we work.
Personal by design
Each solution is built from the patient’s own tumor profile and organoid results.
Together with your doctor
We coordinate with oncologists at every step. Medical decisions stay with the patient’s medical team.
Quality you can trace
We record every sample, cell product and analysis so it can be traced from start to finish.
Clear and honest
We explain what each option involves, what it costs and what results can and cannot be expected.
Based in Hong Kong, connected across the Greater Bay Area.
Hong Kong is our home and coordination center. We are building a network of laboratory, manufacturing and medical partners across the region, and will name partners once agreements are in place.
Let’s talk about precision cell science.
Doctors can refer a patient, and hospitals, laboratories and investors can explore a partnership. Patients are welcome to contact us; any medical decision is made with your own doctor.